activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	2470213	CHEMBL983615	Inhibition of LIMK2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5932	Homo sapiens	INH	%	10.0
	2470213	CHEMBL983615	Inhibition of LIMK2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5932	Homo sapiens	INH	%	10.0
	2476672	CHEMBL1025744	Binding affinity to human LIMK2 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	3.3	CHEMBL5932	Homo sapiens	Activity	%	3.3
Not Evaluated	2476875	CHEMBL1025744	Binding affinity to human LIMK2 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL5932	Homo sapiens	Activity		
Not Evaluated	2478714	CHEMBL1025744	Binding affinity to human LIMK2 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL5932	Homo sapiens	Activity		
	2479566	CHEMBL988959	Binding affinity to human LIMK2	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337	>	Kd	nM	40000.0	CHEMBL5932	Homo sapiens	Kd	nM	40000.0
Not Evaluated	2479772	CHEMBL1025744	Binding affinity to human LIMK2 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL5932	Homo sapiens	Activity		
Not Evaluated	2480569	CHEMBL1025744	Binding affinity to human LIMK2 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL5932	Homo sapiens	Activity		
Not Evaluated	2480771	CHEMBL1025744	Binding affinity to human LIMK2 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL5932	Homo sapiens	Activity		
Not Evaluated	2577393	CHEMBL1025744	Binding affinity to human LIMK2 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL5932	Homo sapiens	Activity		
	2593598	CHEMBL1025744	Binding affinity to human LIMK2 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	9.05	CHEMBL5932	Homo sapiens	Activity	%	9.05
	2593801	CHEMBL1025744	Binding affinity to human LIMK2 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	3.4	CHEMBL5932	Homo sapiens	Activity	%	3.4
Not Evaluated	2593864	CHEMBL1025744	Binding affinity to human LIMK2 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL5932	Homo sapiens	Activity		
Not Evaluated	2594067	CHEMBL1025744	Binding affinity to human LIMK2 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL5932	Homo sapiens	Activity		
Not Evaluated	2595010	CHEMBL1025744	Binding affinity to human LIMK2 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL5932	Homo sapiens	Activity		
Not Evaluated	2595279	CHEMBL1025744	Binding affinity to human LIMK2 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL5932	Homo sapiens	Activity		
Not Evaluated	2596207	CHEMBL1025744	Binding affinity to human LIMK2 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL5932	Homo sapiens	Activity		
Not Evaluated	2596410	CHEMBL1025744	Binding affinity to human LIMK2 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL5932	Homo sapiens	Activity		
Not Evaluated	2597679	CHEMBL1025744	Binding affinity to human LIMK2 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL5932	Homo sapiens	Activity		
Not Evaluated	2597882	CHEMBL1025744	Binding affinity to human LIMK2 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL5932	Homo sapiens	Activity		
	2894200	CHEMBL1063714	Binding constant for full-length LIMK2	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	4700.0	CHEMBL5932	Homo sapiens	Kd	nM	4700.0
	2894201	CHEMBL1063714	Binding constant for full-length LIMK2	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894202	CHEMBL1063714	Binding constant for full-length LIMK2	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894203	CHEMBL1063714	Binding constant for full-length LIMK2	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894204	CHEMBL1063714	Binding constant for full-length LIMK2	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894205	CHEMBL1063714	Binding constant for full-length LIMK2	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894206	CHEMBL1063714	Binding constant for full-length LIMK2	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894207	CHEMBL1063714	Binding constant for full-length LIMK2	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894208	CHEMBL1063714	Binding constant for full-length LIMK2	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894209	CHEMBL1063714	Binding constant for full-length LIMK2	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894210	CHEMBL1063714	Binding constant for full-length LIMK2	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894211	CHEMBL1063714	Binding constant for full-length LIMK2	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	86.0	CHEMBL5932	Homo sapiens	Kd	nM	86.0
	2894212	CHEMBL1063714	Binding constant for full-length LIMK2	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894213	CHEMBL1063714	Binding constant for full-length LIMK2	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894214	CHEMBL1063714	Binding constant for full-length LIMK2	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894215	CHEMBL1063714	Binding constant for full-length LIMK2	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894216	CHEMBL1063714	Binding constant for full-length LIMK2	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894217	CHEMBL1063714	Binding constant for full-length LIMK2	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	390.0	CHEMBL5932	Homo sapiens	Kd	nM	390.0
	2894218	CHEMBL1063714	Binding constant for full-length LIMK2	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894219	CHEMBL1063714	Binding constant for full-length LIMK2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	1000.0	CHEMBL5932	Homo sapiens	Kd	nM	1000.0
	2894220	CHEMBL1063714	Binding constant for full-length LIMK2	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894221	CHEMBL1063714	Binding constant for full-length LIMK2	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894222	CHEMBL1063714	Binding constant for full-length LIMK2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894223	CHEMBL1063714	Binding constant for full-length LIMK2	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894224	CHEMBL1063714	Binding constant for full-length LIMK2	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Kd	nM	3500.0	CHEMBL5932	Homo sapiens	Kd	nM	3500.0
	2894225	CHEMBL1063714	Binding constant for full-length LIMK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894226	CHEMBL1063714	Binding constant for full-length LIMK2	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894227	CHEMBL1063714	Binding constant for full-length LIMK2	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894228	CHEMBL1063714	Binding constant for full-length LIMK2	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894229	CHEMBL1063714	Binding constant for full-length LIMK2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894230	CHEMBL1063714	Binding constant for full-length LIMK2	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894231	CHEMBL1063714	Binding constant for full-length LIMK2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894232	CHEMBL1063714	Binding constant for full-length LIMK2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	9200.0	CHEMBL5932	Homo sapiens	Kd	nM	9200.0
	2894233	CHEMBL1063714	Binding constant for full-length LIMK2	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894234	CHEMBL1063714	Binding constant for full-length LIMK2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894235	CHEMBL1063714	Binding constant for full-length LIMK2	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	2600.0	CHEMBL5932	Homo sapiens	Kd	nM	2600.0
	2894236	CHEMBL1063714	Binding constant for full-length LIMK2	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2894237	CHEMBL1063714	Binding constant for full-length LIMK2	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	2921292	CHEMBL1049107	Inhibition of LIMK2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	98.0	CHEMBL5932	Homo sapiens	Activity	%	98.0
	2928485	CHEMBL1043877	Binding affinity to LIMK2 assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	78.0	CHEMBL5932	Homo sapiens	Activity	%	78.0
	2939324	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCC(C(=O)Nc4ccccc4)CC3)c12		CHEMBL570598	=	IC50	nM	800.0	CHEMBL5932	Homo sapiens	IC50	nM	800.0
	2939325	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1ccccc1NC(=O)C1CCN(c2ncnc3[nH]cc(C)c23)CC1		CHEMBL578599	=	IC50	nM	11500.0	CHEMBL5932	Homo sapiens	IC50	nM	11500.0
	2939326	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1cccc(NC(=O)C2CCN(c3ncnc4[nH]cc(C)c34)CC2)c1		CHEMBL568938	=	IC50	nM	650.0	CHEMBL5932	Homo sapiens	IC50	nM	650.0
	2939327	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1ccc(NC(=O)C2CCN(c3ncnc4[nH]cc(C)c34)CC2)cc1		CHEMBL570339	=	IC50	nM	1300.0	CHEMBL5932	Homo sapiens	IC50	nM	1300.0
	2939328	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	COc1cccc(NC(=O)C2CCN(c3ncnc4[nH]cc(C)c34)CC2)c1		CHEMBL576712	=	IC50	nM	520.0	CHEMBL5932	Homo sapiens	IC50	nM	520.0
	2939329	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	COc1ccc(NC(=O)C2CCN(c3ncnc4[nH]cc(C)c34)CC2)cc1		CHEMBL576283	=	IC50	nM	1500.0	CHEMBL5932	Homo sapiens	IC50	nM	1500.0
	2939330	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCC(C(=O)Nc4cccc(Oc5ccccc5)c4)CC3)c12		CHEMBL570109	=	IC50	nM	64.0	CHEMBL5932	Homo sapiens	IC50	nM	64.0
	2939331	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCC(C(=O)Nc4cccc(Br)c4)CC3)c12		CHEMBL573004	=	IC50	nM	300.0	CHEMBL5932	Homo sapiens	IC50	nM	300.0
	2939332	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1cccc(NC(=O)N2CCN(c3ncnc4[nH]cc(C)c34)CC2)c1		CHEMBL571715	=	IC50	nM	92.0	CHEMBL5932	Homo sapiens	IC50	nM	92.0
	2939333	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	COc1cccc(NC(=O)N2CCN(c3ncnc4[nH]cc(C)c34)CC2)c1		CHEMBL568706	=	IC50	nM	140.0	CHEMBL5932	Homo sapiens	IC50	nM	140.0
	2939334	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCN(C(=O)Nc4cccc(Br)c4)CC3)c12		CHEMBL571280	=	IC50	nM	38.0	CHEMBL5932	Homo sapiens	IC50	nM	38.0
	2939335	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCN(/C(=N/C#N)Nc4cccc(Br)c4)CC3)c12		CHEMBL568484	=	IC50	nM	11.0	CHEMBL5932	Homo sapiens	IC50	nM	11.0
	2939336	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCN(C(=O)Nc4cccc(Br)c4)[C@@H](C)C3)c12		CHEMBL571942	=	IC50	nM	3.9	CHEMBL5932	Homo sapiens	IC50	nM	3.9
	2939337	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCN(/C(=N/C#N)Nc4cccc(Br)c4)[C@@H](C)C3)c12		CHEMBL570126	=	IC50	nM	0.9	CHEMBL5932	Homo sapiens	IC50	nM	0.9
	2939338	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCN(C(=O)Nc4cccc(Br)c4)[C@H](C)C3)c12		CHEMBL571502	=	IC50	nM	37.0	CHEMBL5932	Homo sapiens	IC50	nM	37.0
	2939339	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCN(/C(=N/C#N)Nc4cccc(Br)c4)[C@@H](C(C)C)C3)c12		CHEMBL570831	=	IC50	nM	4.2	CHEMBL5932	Homo sapiens	IC50	nM	4.2
	2939340	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3C[C@H](C)N(/C(=N/C#N)Nc4cccc(Br)c4)C[C@H]3C)c12		CHEMBL570586	=	IC50	nM	3.9	CHEMBL5932	Homo sapiens	IC50	nM	3.9
	2939341	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3C[C@H](C)N(C(=O)Nc4cccc(Br)c4)[C@H](C)C3)c12		CHEMBL570819	=	IC50	nM	133.0	CHEMBL5932	Homo sapiens	IC50	nM	133.0
	2939342	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CC4CCC(C3)N4C(=O)Nc3cccc(Br)c3)c12		CHEMBL584968	=	IC50	nM	16.0	CHEMBL5932	Homo sapiens	IC50	nM	16.0
	2939343	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CC4CC3CN4/C(=N/C#N)Nc3cccc(Br)c3)c12		CHEMBL571261	=	IC50	nM	76.0	CHEMBL5932	Homo sapiens	IC50	nM	76.0
	2939344	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	CC1CN(c2ncnc3[nH]ccc23)CCN1/C(=N/C#N)Nc1cccc(Br)c1		CHEMBL572371	=	IC50	nM	8.1	CHEMBL5932	Homo sapiens	IC50	nM	8.1
	2939345	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	C[C@H]1CN(c2ncnc3[nH]cc(Cl)c23)CCN1/C(=N/C#N)Nc1cccc(Br)c1		CHEMBL577194	=	IC50	nM	1.2	CHEMBL5932	Homo sapiens	IC50	nM	1.2
	2939346	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1cc2c(N3CCN(/C(=N/C#N)Nc4cccc(Br)c4)[C@@H](C)C3)ncnc2[nH]1		CHEMBL570830	=	IC50	nM	4.2	CHEMBL5932	Homo sapiens	IC50	nM	4.2
	2939347	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	C[C@H]1CN(c2nc(Cl)nc3[nH]ccc23)CCN1/C(=N/C#N)Nc1cccc(Br)c1		CHEMBL571485	>	IC50	nM	1000.0	CHEMBL5932	Homo sapiens	IC50	nM	1000.0
	2939348	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCN(/C(=N/S(C)(=O)=O)Nc4cccc(Br)c4)[C@@H](C)C3)c12		CHEMBL571706	=	IC50	nM	6.8	CHEMBL5932	Homo sapiens	IC50	nM	6.8
	2939349	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCN(/C(=N/C#N)Nc4cccc(Cl)c4)[C@@H](C)C3)c12		CHEMBL570832	=	IC50	nM	1.6	CHEMBL5932	Homo sapiens	IC50	nM	1.6
	2939350	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCN(C(=O)Nc4cccc(Cl)c4)[C@@H](C)C3)c12		CHEMBL583464	=	IC50	nM	2.3	CHEMBL5932	Homo sapiens	IC50	nM	2.3
	2939351	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCN(/C(=N/C#N)Nc4cccc(F)c4)[C@@H](C)C3)c12		CHEMBL584090	=	IC50	nM	1.8	CHEMBL5932	Homo sapiens	IC50	nM	1.8
	2939352	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCN(/C(=N/C#N)Nc4ccc(F)c(Br)c4)[C@@H](C)C3)c12		CHEMBL565452	=	IC50	nM	1.5	CHEMBL5932	Homo sapiens	IC50	nM	1.5
	2939353	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCN(C(=O)Nc4ccc(F)c(Br)c4)[C@@H](C)C3)c12		CHEMBL570820	=	IC50	nM	3.2	CHEMBL5932	Homo sapiens	IC50	nM	3.2
	2939354	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCN(/C(=N/C#N)Nc4cccc(C(F)(F)F)c4)[C@@H](C)C3)c12		CHEMBL571947	=	IC50	nM	1.9	CHEMBL5932	Homo sapiens	IC50	nM	1.9
	2939355	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCN(/C(=N/C#N)Nc4cccc(C#N)c4)[C@@H](C)C3)c12		CHEMBL569861	=	IC50	nM	1.2	CHEMBL5932	Homo sapiens	IC50	nM	1.2
	2939356	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCN(/C(=N/C#N)Nc4cccc(C(C)(C)C)c4)[C@@H](C)C3)c12		CHEMBL570115	=	IC50	nM	1.1	CHEMBL5932	Homo sapiens	IC50	nM	1.1
	2939357	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCN(C(=O)Nc4cccc(OC(=O)N(C)C)c4)[C@@H](C)C3)c12		CHEMBL570116	=	IC50	nM	1.2	CHEMBL5932	Homo sapiens	IC50	nM	1.2
	2939358	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCN(/C(=N/C#N)Nc4cccc(C(=O)NC(C)C)c4)[C@@H](C)C3)c12		CHEMBL585734	=	IC50	nM	3.5	CHEMBL5932	Homo sapiens	IC50	nM	3.5
	2939359	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCN(C(=O)Nc4cccc(C(=O)NC(C)C)c4)[C@@H](C)C3)c12		CHEMBL572170	=	IC50	nM	5.5	CHEMBL5932	Homo sapiens	IC50	nM	5.5
	2939360	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCN(/C(=N/C#N)Nc4cccc(C(=O)NCCO)c4)[C@@H](C)C3)c12		CHEMBL571057	=	IC50	nM	0.8	CHEMBL5932	Homo sapiens	IC50	nM	0.8
	2939361	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCN(C(=O)Nc4cccc(C(=O)NCCO)c4)[C@@H](C)C3)c12		CHEMBL570821	=	IC50	nM	3.0	CHEMBL5932	Homo sapiens	IC50	nM	3.0
	2939362	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCN(C(=O)Nc4cccc(C(=O)NC(CO)CO)c4)[C@@H](C)C3)c12		CHEMBL578615	=	IC50	nM	3.0	CHEMBL5932	Homo sapiens	IC50	nM	3.0
	2939363	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCN(/C(=N/C#N)Nc4cccc(C(=O)NCCN(C)C)c4)[C@@H](C)C3)c12		CHEMBL571940	=	IC50	nM	3.4	CHEMBL5932	Homo sapiens	IC50	nM	3.4
	2939364	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCN(/C(=N/C#N)Nc4cccc(S(=O)(=O)NC(C)C)c4)[C@@H](C)C3)c12		CHEMBL566746	=	IC50	nM	1.7	CHEMBL5932	Homo sapiens	IC50	nM	1.7
	2939365	CHEMBL1036965	Inhibition of human recombinant LIMK2 expressed in baculovirus-Sf9 system by scintillation counting	B	Cc1c[nH]c2ncnc(N3CCN(/C(=N/C#N)Nc4cccc(S(=O)(=O)NCCO)c4)[C@@H](C)C3)c12		CHEMBL565453	=	IC50	nM	2.9	CHEMBL5932	Homo sapiens	IC50	nM	2.9
	3331998	CHEMBL1166048	Inhibition of LIMK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL5932	Homo sapiens	INH	%	50.0
	3333413	CHEMBL1166048	Inhibition of LIMK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL5932	Homo sapiens	INH	%	50.0
	3334818	CHEMBL1166048	Inhibition of LIMK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL5932	Homo sapiens	INH	%	50.0
	3336238	CHEMBL1166048	Inhibition of LIMK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL5932	Homo sapiens	INH	%	50.0
	3337567	CHEMBL1166048	Inhibition of LIMK2 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL5932	Homo sapiens	INH	%	50.0
	3338898	CHEMBL1166048	Inhibition of LIMK2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL5932	Homo sapiens	INH	%	50.0
	3339152	CHEMBL1166048	Inhibition of LIMK2 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL5932	Homo sapiens	INH	%	50.0
	3340455	CHEMBL1166048	Inhibition of LIMK2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL5932	Homo sapiens	INH	%	50.0
	3341780	CHEMBL1166048	Inhibition of LIMK2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL5932	Homo sapiens	INH	%	50.0
	3343227	CHEMBL1166048	Inhibition of LIMK2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL5932	Homo sapiens	INH	%	50.0
	3358637	CHEMBL1174879	Inhibition of LIMK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	11.0	CHEMBL5932	Homo sapiens	INH	%	11.0
	3359079	CHEMBL1174879	Inhibition of LIMK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.35	CHEMBL5932	Homo sapiens	INH	%	0.35
	3448475	CHEMBL1244482	Binding affinity to LIMK2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	3448769	CHEMBL1244482	Binding affinity to LIMK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	3449710	CHEMBL1244482	Binding affinity to LIMK2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	3449937	CHEMBL1244482	Binding affinity to LIMK2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	3450115	CHEMBL1244482	Binding affinity to LIMK2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	3450351	CHEMBL1244482	Binding affinity to LIMK2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	3451034	CHEMBL1244482	Binding affinity to LIMK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	uM	10.0
	3499105	CHEMBL1259854	Inhibition of LIMK2	B	CC(C)Nc1ncc(-c2cc(-c3ccccc3Cl)nc(-c3ccccn3)n2)s1		CHEMBL1258633	=	IC50	nM	362.0	CHEMBL5932	Homo sapiens	IC50	nM	362.0
	3499106	CHEMBL1259854	Inhibition of LIMK2	B	CC(C)Nc1ncc(-c2cc(-c3ccccc3Cl)nc(NCCN(C)C)n2)s1		CHEMBL1258976	=	IC50	nM	3.05	CHEMBL5932	Homo sapiens	IC50	nM	3.05
	6340025	CHEMBL1826930	Activity of LIMK2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	89.0	CHEMBL5932	Homo sapiens	Activity	%	89.0
	7567419	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7567907	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7568375	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	310.0	CHEMBL5932	Homo sapiens	Kd	nM	310.0
	7568807	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7569410	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7569882	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7570345	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7570772	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7570926	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7571383	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	690.0	CHEMBL5932	Homo sapiens	Kd	nM	690.0
	7571859	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7572322	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Kd	nM	3500.0	CHEMBL5932	Homo sapiens	Kd	nM	3500.0
	7572738	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	1100.0	CHEMBL5932	Homo sapiens	Kd	nM	1100.0
	7572907	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7573364	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	86.0	CHEMBL5932	Homo sapiens	Kd	nM	86.0
	7573840	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7574309	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7574717	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7574885	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7575346	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7575817	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	500.0	CHEMBL5932	Homo sapiens	Kd	nM	500.0
	7576282	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	620.0	CHEMBL5932	Homo sapiens	Kd	nM	620.0
	7576859	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7577318	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	1700.0	CHEMBL5932	Homo sapiens	Kd	nM	1700.0
	7577796	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7578229	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	7900.0	CHEMBL5932	Homo sapiens	Kd	nM	7900.0
	7578867	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7579241	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7579691	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7580192	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7580595	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7581225	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7581610	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7582055	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7582084	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7582548	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7582948	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	2600.0	CHEMBL5932	Homo sapiens	Kd	nM	2600.0
	7583571	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	4700.0	CHEMBL5932	Homo sapiens	Kd	nM	4700.0
	7583968	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7584442	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7584904	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	1400.0	CHEMBL5932	Homo sapiens	Kd	nM	1400.0
	7585308	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7586313	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7586784	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7587238	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7587420	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7587839	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7588292	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7588763	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7589214	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7589385	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7589809	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7590276	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7590750	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7591201	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7591358	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7591780	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7592252	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7592725	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7593325	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	1800.0	CHEMBL5932	Homo sapiens	Kd	nM	1800.0
	7593760	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7594232	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7594715	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7595293	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7595737	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7596211	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7596240	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7596687	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	9600.0	CHEMBL5932	Homo sapiens	Kd	nM	9600.0
	7597265	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7597718	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL5932	Homo sapiens	Kd	nM	10000.0
	7598219	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	390.0	CHEMBL5932	Homo sapiens	Kd	nM	390.0
	7598661	CHEMBL1908718	Binding constant for LIMK2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	9200.0	CHEMBL5932	Homo sapiens	Kd	nM	9200.0
	10990849	CHEMBL2071841	Inhibition of LIMK2	B	CCCNc1ncc(-c2cc(-c3ccc(O)cc3Cl)nc(-c3cnccn3)n2)s1		CHEMBL2070492	>	IC50	nM	12500.0	CHEMBL5932	Homo sapiens	IC50	nM	12500.0
	10990850	CHEMBL2071841	Inhibition of LIMK2	B	CCCNc1ncc(-c2cc(-c3ccc(OC)cc3Cl)nc(-c3cnccn3)n2)s1		CHEMBL2070493	=	IC50	nM	1232.0	CHEMBL5932	Homo sapiens	IC50	nM	1232.0
	10990851	CHEMBL2071841	Inhibition of LIMK2	B	CCCCCOc1ccc(-c2cc(-c3cnc(NCCC)s3)nc(-c3cnccn3)n2)c(Cl)c1		CHEMBL2070494	=	IC50	nM	1545.0	CHEMBL5932	Homo sapiens	IC50	nM	1545.0
	10990852	CHEMBL2071841	Inhibition of LIMK2	B	CCCNc1ncc(-c2cc(-c3ccc(OC(CC)CC)cc3Cl)nc(-c3cnccn3)n2)s1		CHEMBL2070495	=	IC50	nM	50000.0	CHEMBL5932	Homo sapiens	IC50	nM	50000.0
	10990853	CHEMBL2071841	Inhibition of LIMK2	B	CCCNc1ncc(-c2cc(-c3ccc(OC4CCCC4)cc3Cl)nc(-c3cnccn3)n2)s1		CHEMBL2070496	=	IC50	nM	50000.0	CHEMBL5932	Homo sapiens	IC50	nM	50000.0
	10990854	CHEMBL2071841	Inhibition of LIMK2	B	CCCNc1ncc(-c2cc(-c3c(Cl)cc(OC)cc3Cl)nc(-c3cnccn3)n2)s1		CHEMBL2070497	=	IC50	nM	16.0	CHEMBL5932	Homo sapiens	IC50	nM	16.0
	10990855	CHEMBL2071841	Inhibition of LIMK2	B	CCCNc1ncc(-c2cc(-c3c(Cl)cc(OCCC)cc3Cl)nc(-c3cnccn3)n2)s1		CHEMBL2070498	=	IC50	nM	141.0	CHEMBL5932	Homo sapiens	IC50	nM	141.0
	10990856	CHEMBL2071841	Inhibition of LIMK2	B	CCCNc1ncc(-c2cc(-c3c(Cl)cc(OC4CCCC4)cc3Cl)nc(-c3cnccn3)n2)s1		CHEMBL2070499	=	IC50	nM	810.0	CHEMBL5932	Homo sapiens	IC50	nM	810.0
	10990857	CHEMBL2071841	Inhibition of LIMK2	B	CCCNc1ncc(-c2cc(-c3c(Cl)cc(OC(CC)CC)cc3Cl)nc(-c3cnccn3)n2)s1		CHEMBL2070500	=	IC50	nM	1531.0	CHEMBL5932	Homo sapiens	IC50	nM	1531.0
	10990858	CHEMBL2071841	Inhibition of LIMK2	B	CCCNc1ncc(-c2cc(-c3ccc(OC(CC)CC)cc3C)nc(-c3cnccn3)n2)s1		CHEMBL2070501	=	IC50	nM	1222.0	CHEMBL5932	Homo sapiens	IC50	nM	1222.0
	10990859	CHEMBL2071841	Inhibition of LIMK2	B	CCCNc1ncc(-c2cc(-c3cc(OC)ccc3Cl)nc(-c3cnccn3)n2)s1		CHEMBL2070502	=	IC50	nM	760.0	CHEMBL5932	Homo sapiens	IC50	nM	760.0
	10990860	CHEMBL2071841	Inhibition of LIMK2	B	CCCNc1ncc(-c2cc(-c3cc(OCCC)ccc3Cl)nc(-c3cnccn3)n2)s1		CHEMBL2070503	=	IC50	nM	171.0	CHEMBL5932	Homo sapiens	IC50	nM	171.0
	10990861	CHEMBL2071841	Inhibition of LIMK2	B	CCCNc1ncc(-c2cc(-c3cc(OCCC4CCCCC4)ccc3Cl)nc(-c3cnccn3)n2)s1		CHEMBL2070504	=	IC50	nM	28.0	CHEMBL5932	Homo sapiens	IC50	nM	28.0
	10990862	CHEMBL2071841	Inhibition of LIMK2	B	CCC(CC)Oc1cc(C)c(-c2cc(-c3cnc(NC(=O)OC)s3)nc(-c3cnccn3)n2)c(C)c1		CHEMBL2070505	=	IC50	nM	382.0	CHEMBL5932	Homo sapiens	IC50	nM	382.0
	10990863	CHEMBL2071841	Inhibition of LIMK2	B	CCC(CC)Oc1cc(C)c(-c2cc(-c3cnc(NC(C)=O)s3)nc(-c3cnccn3)n2)c(C)c1		CHEMBL2070611	=	IC50	nM	311.0	CHEMBL5932	Homo sapiens	IC50	nM	311.0
	10990864	CHEMBL2071841	Inhibition of LIMK2	B	CCC(CC)Oc1cc(C)c(-c2cc(-c3cnc(NC(=O)C(C)C)s3)nc(-c3cnccn3)n2)c(C)c1		CHEMBL2070612	=	IC50	nM	245.0	CHEMBL5932	Homo sapiens	IC50	nM	245.0
	10990865	CHEMBL2071841	Inhibition of LIMK2	B	CCC(CC)Oc1cc(C)c(-c2cc(-c3cnc(NC(=O)NC)s3)nc(-c3cnccn3)n2)c(C)c1		CHEMBL2070613	=	IC50	nM	173.0	CHEMBL5932	Homo sapiens	IC50	nM	173.0
	10990866	CHEMBL2071841	Inhibition of LIMK2	B	CNC(=O)Nc1ncc(-c2cc(-c3c(C)cc(OC)cc3C)nc(-c3cnccn3)n2)s1		CHEMBL2070614	=	IC50	nM	16.0	CHEMBL5932	Homo sapiens	IC50	nM	16.0
	10990867	CHEMBL2071841	Inhibition of LIMK2	B	CCNC(=O)Nc1ncc(-c2cc(-c3c(C)cc(OC)cc3C)nc(-c3cnccn3)n2)s1		CHEMBL2070615	=	IC50	nM	38.0	CHEMBL5932	Homo sapiens	IC50	nM	38.0
	10990868	CHEMBL2071841	Inhibition of LIMK2	B	COc1cc(C)c(-c2cc(-c3cnc(NC(C)=O)s3)nc(-c3cnccn3)n2)c(C)c1		CHEMBL2070616	=	IC50	nM	59.0	CHEMBL5932	Homo sapiens	IC50	nM	59.0
	10990869	CHEMBL2071841	Inhibition of LIMK2	B	COC(=O)Nc1ncc(-c2cc(-c3c(C)cc(OC)cc3C)nc(-c3cnccn3)n2)s1		CHEMBL2070617	=	IC50	nM	202.0	CHEMBL5932	Homo sapiens	IC50	nM	202.0
	10990870	CHEMBL2071841	Inhibition of LIMK2	B	CNC(=O)Nc1ncc(-c2cc(-c3c(Cl)cc(OC)cc3Cl)nc(-c3cnccn3)n2)s1		CHEMBL2070618	=	IC50	nM	12.0	CHEMBL5932	Homo sapiens	IC50	nM	12.0
	10990871	CHEMBL2071841	Inhibition of LIMK2	B	COc1cc(Cl)c(-c2cc(-c3cnc(NC(C)=O)s3)nc(-c3cnccn3)n2)c(Cl)c1		CHEMBL2070619	=	IC50	nM	8.0	CHEMBL5932	Homo sapiens	IC50	nM	8.0
Dose-dependent effect	10990922	CHEMBL2071847	Inhibition of LIMK2-mediated cofilin Ser3 phosphorylation in human HT1080 cells	B	CCNC(=O)Nc1ncc(-c2cc(-c3c(C)cc(OC)cc3C)nc(-c3cnccn3)n2)s1		CHEMBL2070615		Inhibition	%		CHEMBL5932	Homo sapiens	INH		
Active	10990930	CHEMBL2071855	Binding affinity to human LIMK2	B	CCNC(=O)Nc1ncc(-c2cc(-c3c(C)cc(OC)cc3C)nc(-c3cnccn3)n2)s1		CHEMBL2070615		Activity			CHEMBL5932	Homo sapiens	Activity		
	12172380	CHEMBL2210645	Inhibition of LIMK2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL5932	Homo sapiens	Activity	%	100.0
	12183870	CHEMBL2211518	Inhibition of LIMK2	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL5932	Homo sapiens	pIC50		5.0
	13375822	CHEMBL2404333	Inhibition of LIMK2 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	4.0	CHEMBL5932	Homo sapiens	INH	%	4.0
	13439828	CHEMBL2426973	Competitive binding affinity to LIMK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	=	Inhibition	%	81.0	CHEMBL5932	Homo sapiens	INH	%	81.0
	13442419	CHEMBL2426973	Competitive binding affinity to LIMK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	CS(=O)(=O)CCCOc1cccc2c1ccn2-c1ccnc(N[C@H]2CC[C@H](C(=O)N3CCC(O)CC3)CC2)n1		CHEMBL2425628	>	Inhibition	%	85.0	CHEMBL5932	Homo sapiens	INH	%	85.0
	13442488	CHEMBL2429182	Binding affinity to LIMK2 (unknown origin)	B	CS(=O)(=O)CCCOc1cccc2c1ccn2-c1ccnc(N[C@H]2CC[C@H](C(=O)N3CCC(O)CC3)CC2)n1		CHEMBL2425628	=	Kd	nM	2800.0	CHEMBL5932	Homo sapiens	Kd	uM	2.8
	13442635	CHEMBL2426973	Competitive binding affinity to LIMK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	100.0	CHEMBL5932	Homo sapiens	INH	%	100.0
	13445661	CHEMBL2426973	Competitive binding affinity to LIMK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	76.0	CHEMBL5932	Homo sapiens	INH	%	76.0
	13451648	CHEMBL2426973	Competitive binding affinity to LIMK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	78.0	CHEMBL5932	Homo sapiens	INH	%	78.0
	14927013	CHEMBL3391341	Inhibition of LIMK2 (unknown origin)	B	CCNC(=O)Nc1ncc(-c2cc(-c3c(C)cc(OC)cc3C)nc(-c3cnccn3)n2)s1		CHEMBL2070615	=	IC50	nM	696.0	CHEMBL5932	Homo sapiens	IC50	nM	696.0
	14927014	CHEMBL3391341	Inhibition of LIMK2 (unknown origin)	B	CC(C)C(=O)Nc1ncc(-c2cc(C(F)F)nn2-c2c(Cl)cccc2Cl)s1		CHEMBL2141887	=	IC50	nM	85.0	CHEMBL5932	Homo sapiens	IC50	nM	85.0
	14927015	CHEMBL3391341	Inhibition of LIMK2 (unknown origin)	B	Nc1ncnc2c1sc1cc(-c3cccc(C(=O)NCCc4cccnc4)c3)ccc12		CHEMBL3347513	=	IC50	nM	133.0	CHEMBL5932	Homo sapiens	IC50	nM	133.0
	14927016	CHEMBL3391341	Inhibition of LIMK2 (unknown origin)	B	CN1CCN(C(=O)Nc2cccc(-c3ccc4c(c3)sc3c(N)ncnc34)c2)CC1		CHEMBL3347683	=	IC50	nM	157.0	CHEMBL5932	Homo sapiens	IC50	nM	157.0
	14927017	CHEMBL3391341	Inhibition of LIMK2 (unknown origin)	B	Nc1ncnc2c1sc1cc(-c3cccc(NC(=O)N4CCCC4)c3)ccc12		CHEMBL3347669	=	IC50	nM	103.0	CHEMBL5932	Homo sapiens	IC50	nM	103.0
	14927018	CHEMBL3391341	Inhibition of LIMK2 (unknown origin)	B	CCNC(=O)Nc1cccc(-c2ccc3c(c2)sc2c(N)ncnc23)c1		CHEMBL3347528	=	IC50	nM	164.0	CHEMBL5932	Homo sapiens	IC50	nM	164.0
	14927019	CHEMBL3391341	Inhibition of LIMK2 (unknown origin)	B	Nc1ncnc2c1sc1cc(-c3cccc(-c4nn[nH]n4)c3)ccc12		CHEMBL3347507	=	IC50	nM	90.0	CHEMBL5932	Homo sapiens	IC50	nM	90.0
	14927020	CHEMBL3391341	Inhibition of LIMK2 (unknown origin)	B	NC(=O)c1cccc(-c2ccc3c(c2)sc2c(N)ncnc23)c1		CHEMBL3347689	=	IC50	nM	273.0	CHEMBL5932	Homo sapiens	IC50	nM	273.0
	14980861	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	O=S(=O)(Nc1ccccc1)c1ccc(-c2nccnc2Cc2ccccc2)cc1		CHEMBL3355517	=	IC50	nM	90.0	CHEMBL5932	Homo sapiens	IC50	uM	0.09
	14980862	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	O=S(=O)(Nc1ccccc1)c1ccc(-c2ncccc2Cc2ccccc2)cc1		CHEMBL3355516	=	IC50	nM	100.0	CHEMBL5932	Homo sapiens	IC50	uM	0.1
	14980863	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	O=S(=O)(Nc1ccccc1)c1ccc(-c2nccn2Cc2ccccc2)cc1		CHEMBL3355515	=	IC50	nM	22.0	CHEMBL5932	Homo sapiens	IC50	uM	0.022
	14980864	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	O=c1ccnc(-c2ccc(S(=O)(=O)Nc3ccccc3)cc2)n1Cc1ccccc1		CHEMBL3355514	>	IC50	nM	27000.0	CHEMBL5932	Homo sapiens	IC50	uM	27.0
	14980865	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	O=S(=O)(Nc1ccccc1)c1ccc(-c2ocnc2Cc2ccccc2)cc1		CHEMBL3355513	=	IC50	nM	1530.0	CHEMBL5932	Homo sapiens	IC50	uM	1.53
	14980866	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	NCCCN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1		CHEMBL3355512	=	IC50	nM	1500.0	CHEMBL5932	Homo sapiens	IC50	uM	1.5
	14980867	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	NCCN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1		CHEMBL3355511	=	IC50	nM	1200.0	CHEMBL5932	Homo sapiens	IC50	uM	1.2
	14980868	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	CN(C)CCN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1		CHEMBL3355510	=	IC50	nM	160.0	CHEMBL5932	Homo sapiens	IC50	uM	0.16
	14980869	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	N#CCCN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1		CHEMBL3355509	=	IC50	nM	52.0	CHEMBL5932	Homo sapiens	IC50	uM	0.052
	14980870	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	O=C(c1ccc(S(=O)(=O)Nc2ccccc2)cc1)N(CCO)Cc1ccccc1		CHEMBL3355508	=	IC50	nM	19.0	CHEMBL5932	Homo sapiens	IC50	uM	0.019
	14980871	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	CCN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1		CHEMBL3355507	=	IC50	nM	3.0	CHEMBL5932	Homo sapiens	IC50	uM	0.003
	14980872	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	C[C@H](c1ccccc1)N(C)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1		CHEMBL3355506	=	IC50	nM	120.0	CHEMBL5932	Homo sapiens	IC50	uM	0.12
	14980873	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	C[C@@H](c1ccccc1)N(C)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1		CHEMBL3355505	=	IC50	nM	110.0	CHEMBL5932	Homo sapiens	IC50	uM	0.11
	14980874	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	CC(C)N1CCC(CN(C)C(=O)c2ccc(S(=O)(=O)Nc3ccccc3)cc2)CC1		CHEMBL3355504	>	IC50	nM	27000.0	CHEMBL5932	Homo sapiens	IC50	uM	27.0
	14980875	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	CN1CCC(CN(C)C(=O)c2ccc(S(=O)(=O)Nc3ccccc3)cc2)CC1		CHEMBL3355503	>	IC50	nM	27000.0	CHEMBL5932	Homo sapiens	IC50	uM	27.0
	14980876	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	CN(CC1CCNCC1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1		CHEMBL3355502	>	IC50	nM	27000.0	CHEMBL5932	Homo sapiens	IC50	uM	27.0
	14980877	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	CN(CC1CCN(C(=O)OC(C)(C)C)CC1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1		CHEMBL3355501	=	IC50	nM	36.0	CHEMBL5932	Homo sapiens	IC50	uM	0.036
	14980878	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	CC(=O)N1CCC(CN(C)C(=O)c2ccc(S(=O)(=O)Nc3ccccc3)cc2)CC1		CHEMBL3355500	=	IC50	nM	900.0	CHEMBL5932	Homo sapiens	IC50	uM	0.9
	14980879	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	CN(Cc1ccc(C2CCNCC2)cc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1		CHEMBL3355499	=	IC50	nM	1640.0	CHEMBL5932	Homo sapiens	IC50	uM	1.64
	14980880	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	CN(Cc1ccc(C(O)CO)cc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1		CHEMBL3355498	=	IC50	nM	92.0	CHEMBL5932	Homo sapiens	IC50	uM	0.092
	14980881	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	CN(Cc1ccc(CCC(=O)O)cc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1		CHEMBL3355497	=	IC50	nM	19.0	CHEMBL5932	Homo sapiens	IC50	uM	0.019
	14980882	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	COCCOc1ccc(CN(C)C(=O)c2ccc(S(=O)(=O)Nc3ccccc3)cc2)cc1		CHEMBL3355496	=	IC50	nM	34.0	CHEMBL5932	Homo sapiens	IC50	uM	0.034
	14980883	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	CCc1ccc(CN(C)C(=O)c2ccc(S(=O)(=O)Nc3ccccc3)cc2)cc1		CHEMBL3355495	=	IC50	nM	53.0	CHEMBL5932	Homo sapiens	IC50	uM	0.053
	14980884	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	CN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)N(C)c2ccccc2)cc1		CHEMBL1711204	=	IC50	nM	95.0	CHEMBL5932	Homo sapiens	IC50	uM	0.095
	14980885	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	CN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2cccc(N(C)C)c2)cc1		CHEMBL3355494	>	IC50	nM	27000.0	CHEMBL5932	Homo sapiens	IC50	uM	27.0
	14980886	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	CN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2cccc(C(C)(C)C)c2)cc1		CHEMBL3355493	>	IC50	nM	27000.0	CHEMBL5932	Homo sapiens	IC50	uM	27.0
	14980887	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	COc1cccc(NS(=O)(=O)c2ccc(C(=O)N(C)Cc3ccccc3)cc2)c1		CHEMBL3355492	=	IC50	nM	540.0	CHEMBL5932	Homo sapiens	IC50	uM	0.54
	14980888	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	Cc1cccc(NS(=O)(=O)c2ccc(C(=O)N(C)Cc3ccccc3)cc2)c1		CHEMBL3355491	=	IC50	nM	22.0	CHEMBL5932	Homo sapiens	IC50	uM	0.022
	14980889	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	CN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2cccc(Cl)c2)cc1		CHEMBL3355490	=	IC50	nM	51.0	CHEMBL5932	Homo sapiens	IC50	uM	0.051
	14980890	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	CN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2cccc(F)c2)cc1		CHEMBL3355489	=	IC50	nM	22.0	CHEMBL5932	Homo sapiens	IC50	uM	0.022
	14980891	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	COc1ccc(NS(=O)(=O)c2ccc(C(=O)N(C)Cc3ccccc3)cc2)cc1		CHEMBL3355488	=	IC50	nM	24100.0	CHEMBL5932	Homo sapiens	IC50	uM	24.1
	14980892	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	Cc1ccc(NS(=O)(=O)c2ccc(C(=O)N(C)Cc3ccccc3)cc2)cc1		CHEMBL3355487	=	IC50	nM	3200.0	CHEMBL5932	Homo sapiens	IC50	uM	3.2
	14980893	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	CN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2ccc(F)cc2)cc1		CHEMBL3355486	=	IC50	nM	81.0	CHEMBL5932	Homo sapiens	IC50	uM	0.081
	14980894	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	COc1ccccc1NS(=O)(=O)c1ccc(C(=O)N(C)Cc2ccccc2)cc1		CHEMBL3355485	=	IC50	nM	1000.0	CHEMBL5932	Homo sapiens	IC50	uM	1.0
	14980895	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	Cc1ccccc1NS(=O)(=O)c1ccc(C(=O)N(C)Cc2ccccc2)cc1		CHEMBL3355484	=	IC50	nM	120.0	CHEMBL5932	Homo sapiens	IC50	uM	0.12
	14980896	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	CN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2F)cc1		CHEMBL3355483	=	IC50	nM	52.0	CHEMBL5932	Homo sapiens	IC50	uM	0.052
	14980897	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	CN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1		CHEMBL3355482	=	IC50	nM	39.0	CHEMBL5932	Homo sapiens	IC50	uM	0.039
	14980898	CHEMBL3372433	Inhibition of human full-length LIMK2 expressed in Sf9 cells assessed as incorporation of [33P] from ATP into biotinylated-cofilin substrate in presence of 300 uM ATP	B	CN(Cc1ccccc1)C(=O)c1ccc(NS(=O)(=O)c2cccs2)cc1		CHEMBL3355481	=	IC50	nM	2320.0	CHEMBL5932	Homo sapiens	IC50	uM	2.32
	14982806	CHEMBL3377887	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP	B	Cc1c[nH]c2ncnc(N3CCC(CN)(C(=O)Nc4cccc(OC(=O)N(C)C)c4)CC3)c12		CHEMBL3356433	=	IC50	nM	4.3	CHEMBL5932	Homo sapiens	IC50	nM	4.3
	14982807	CHEMBL3377887	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP	B	Cc1c[nH]c2ncnc(N3CCC(CCN(C)C)(C(=O)Nc4cccc(OC(=O)N(C)C)c4)CC3)c12		CHEMBL3356432	=	IC50	nM	7.3	CHEMBL5932	Homo sapiens	IC50	nM	7.3
	14982808	CHEMBL3377887	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP	B	Cc1c[nH]c2ncnc(N3CCC(Cc4c[nH]cn4)(C(=O)Nc4cccc(OC(=O)N(C)C)c4)CC3)c12		CHEMBL3356431	=	IC50	nM	1.0	CHEMBL5932	Homo sapiens	IC50	nM	1.0
	14982809	CHEMBL3377887	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP	B	COCCOCC1(C(=O)Nc2cccc(OC(=O)N(C)C)c2)CCN(c2ncnc3[nH]cc(C)c23)CC1		CHEMBL3356430	=	IC50	nM	2.7	CHEMBL5932	Homo sapiens	IC50	nM	2.7
	14982810	CHEMBL3377887	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP	B	Cc1c[nH]c2ncnc(N3CCC(C(=O)Nc4cccc(OC(=O)N(C)C)c4)(N(C)C)CC3)c12		CHEMBL3356429	=	IC50	nM	5.1	CHEMBL5932	Homo sapiens	IC50	nM	5.1
	14982811	CHEMBL3377887	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP	B	Cc1c[nH]c2ncnc(N3CCC(O)(C(=O)Nc4cccc(OC(=O)N(C)C)c4)CC3)c12		CHEMBL3356428	=	IC50	nM	138.0	CHEMBL5932	Homo sapiens	IC50	nM	138.0
	14982812	CHEMBL3377887	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP	B	Cc1c[nH]c2ncnc(N3CCC(C)(C(=O)Nc4cccc(OC(=O)N(C)C)c4)CC3)c12		CHEMBL3356427	=	IC50	nM	4.8	CHEMBL5932	Homo sapiens	IC50	nM	4.8
	14982813	CHEMBL3377887	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP	B	C=CCC1(C(=O)Nc2cccc(OC(=O)N(C)C)c2)CCN(c2ncnc3[nH]cc(C)c23)CC1		CHEMBL3356426	=	IC50	nM	2.2	CHEMBL5932	Homo sapiens	IC50	nM	2.2
	14982814	CHEMBL3377887	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP	B	Cc1c[nH]c2ncnc(N3CCC(C)(C(=O)Nc4cccc(C(C)(C)C)c4)CC3)c12		CHEMBL3356425	=	IC50	nM	3.2	CHEMBL5932	Homo sapiens	IC50	nM	3.2
	14982815	CHEMBL3377887	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP	B	C=CCC1(C(=O)Nc2cccc(Cl)c2)CCN(c2ncnc3[nH]cc(C)c23)CC1		CHEMBL3356424	=	IC50	nM	1.9	CHEMBL5932	Homo sapiens	IC50	nM	1.9
	14982816	CHEMBL3377887	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP	B	Cc1c[nH]c2ncnc(N3CC[C@H](C(=O)Nc4cccc(OC(=O)N(C)C)c4)[C@H](C)C3)c12		CHEMBL3356423	=	IC50	nM	110.0	CHEMBL5932	Homo sapiens	IC50	nM	110.0
	14982817	CHEMBL3377887	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP	B	Cc1c[nH]c2ncnc(N3CC[C@H](C(=O)Nc4cccc(OC(=O)N(C)C)c4)[C@@H](C)C3)c12		CHEMBL3356422	=	IC50	nM	210.0	CHEMBL5932	Homo sapiens	IC50	nM	210.0
	14982818	CHEMBL3377887	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP	B	Cc1c[nH]c2ncnc(N3CCC(C(=O)Nc4cccc(OC(C)C)c4)CC3)c12		CHEMBL3356421	=	IC50	nM	330.0	CHEMBL5932	Homo sapiens	IC50	nM	330.0
	14982819	CHEMBL3377887	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP	B	Cc1c[nH]c2ncnc(N3CCN4C(=O)N(c5ccccc5)CC4C3)c12		CHEMBL3356420	>	IC50	nM	1000.0	CHEMBL5932	Homo sapiens	IC50	nM	1000.0
	14982820	CHEMBL3377887	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP	B	Cc1c[nH]c2ncnc(N3CCN(C(=O)Nc4cccc(OC(=O)N(C)C)c4)C(C(C)(C)C)C3)c12		CHEMBL3356419	=	IC50	nM	26.0	CHEMBL5932	Homo sapiens	IC50	nM	26.0
Not Determined	14982821	CHEMBL3377887	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP	B	Cc1c[nH]c2ncnc(N3CCN(C(=O)Nc4cccc(OC(=O)N(C)C)c4)C(C)(C)C3)c12		CHEMBL3356418		IC50			CHEMBL5932	Homo sapiens	IC50		
	14982822	CHEMBL3377887	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP	B	Cc1c[nH]c2ncnc(C3CCN(C(=O)Nc4cccc(OC(=O)N(C)C)c4)CC3)c12		CHEMBL3356068	=	IC50	nM	220.0	CHEMBL5932	Homo sapiens	IC50	nM	220.0
Not Determined	14982823	CHEMBL3377887	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP	B	Cc1c[nH]c2ncnc(N3CCN(C(=O)Nc4cccc(OC(=O)N(C)C)c4)CC3)c12		CHEMBL3356067		IC50			CHEMBL5932	Homo sapiens	IC50		
	14982824	CHEMBL3377887	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP	B	Cc1c[nH]c2ncnc(N3CCN(C(=O)N[C@H](C)c4ccccc4)[C@@H](C)C3)c12		CHEMBL3356066	=	IC50	nM	180.0	CHEMBL5932	Homo sapiens	IC50	nM	180.0
	14982825	CHEMBL3377887	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP	B	Cc1c[nH]c2ncnc(N3CCN(C(=O)N[C@@H](C)c4ccccc4)[C@@H](C)C3)c12		CHEMBL3352853	=	IC50	nM	9.9	CHEMBL5932	Homo sapiens	IC50	nM	9.9
	14982826	CHEMBL3377887	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP	B	Cc1c[nH]c2ncnc(N3CCN(C(=O)Cc4ccccc4)[C@@H](C)C3)c12		CHEMBL3356065	=	IC50	nM	660.0	CHEMBL5932	Homo sapiens	IC50	nM	660.0
	14982827	CHEMBL3377887	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP	B	Cc1c[nH]c2ncnc(N3CCN(C(=O)Nc4ccccc4)[C@@H](C)C3)c12		CHEMBL3356064	=	IC50	nM	1.2	CHEMBL5932	Homo sapiens	IC50	nM	1.2
	14982828	CHEMBL3377887	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP	B	COc1cccc(NC(=O)N2CCN(c3ncnc4[nH]cc(C)c34)C[C@@H]2C)c1		CHEMBL3356063	=	IC50	nM	2.7	CHEMBL5932	Homo sapiens	IC50	nM	2.7
	14982829	CHEMBL3377887	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP	B	Cc1c[nH]c2ncnc(N3CCN(C(=O)Nc4cccc(C(=O)NC(C)C)c4)[C@@H](C)C3)c12		CHEMBL572170	=	IC50	nM	5.5	CHEMBL5932	Homo sapiens	IC50	nM	5.5
	14982830	CHEMBL3377887	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 2 uM ATP	B	Cc1c[nH]c2ncnc(N3CCN(C(=O)Nc4cccc(OC(=O)N(C)C)c4)[C@@H](C)C3)c12		CHEMBL570116	=	IC50	nM	1.2	CHEMBL5932	Homo sapiens	IC50	nM	1.2
	14982857	CHEMBL3378488	Inhibition of human full-length LIMK2 assessed as incorporation of P33 from ATP into biotinylated-cofilin substrate by scintillation counting analysis in presence of 200 uM ATP	B	Cc1c[nH]c2ncnc(N3CCC(CN)(C(=O)Nc4cccc(OC(=O)N(C)C)c4)CC3)c12		CHEMBL3356433	=	IC50	nM	7.5	CHEMBL5932	Homo sapiens	IC50	nM	7.5
	14982865	CHEMBL3378493	Binding affinity to human LIMK2	B	Cc1c[nH]c2ncnc(N3CCC(CN)(C(=O)Nc4cccc(OC(=O)N(C)C)c4)CC3)c12		CHEMBL3356433	<	Kd	nM	1000.0	CHEMBL5932	Homo sapiens	Kd	uM	1.0
	15709837	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	COC(=O)c1ccc(NC(=O)C2(CN(C)C)CCN(c3ncnc4[nH]cc(C)c34)CC2)cc1		CHEMBL3613605	=	IC50	nM	7.7	CHEMBL5932	Homo sapiens	IC50	nM	7.7
	15709838	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	COC(=O)Cc1cccc(NC(=O)C2(CN(C)C)CCN(c3ncnc4[nH]cc(C)c34)CC2)c1		CHEMBL3613604	<	IC50	nM	1.0	CHEMBL5932	Homo sapiens	IC50	nM	1.0
	15709839	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	COC(=O)COc1cccc(NC(=O)C2(CN(C)C)CCN(c3ncnc4[nH]cc(C)c34)CC2)c1		CHEMBL3613603	<	IC50	nM	1.0	CHEMBL5932	Homo sapiens	IC50	nM	1.0
	15709840	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	COC(=O)c1cccc(NC(=O)C2(N(C)C)CCN(c3ncnc4[nH]cc(C)c34)CC2)c1		CHEMBL3613602	=	IC50	nM	12.0	CHEMBL5932	Homo sapiens	IC50	nM	12.0
	15709841	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	COC(=O)c1cccc(NC(=O)C2(N)CCN(c3ncnc4[nH]cc(C)c34)CC2)c1		CHEMBL3613601	=	IC50	nM	7.4	CHEMBL5932	Homo sapiens	IC50	nM	7.4
	15709842	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	COC(=O)c1cccc(NC(=O)C2(CN(C)C)CCN(c3ncnc4[nH]cc(C)c34)CC2)c1		CHEMBL3613600	=	IC50	nM	1.5	CHEMBL5932	Homo sapiens	IC50	nM	1.5
	15709843	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	Cc1c[nH]c2ncnc(N3CCC(CN(C)C)(C(=O)Nc4cccc(OC(=O)N(C)C)c4)CC3)c12		CHEMBL3613599	<	IC50	nM	1.0	CHEMBL5932	Homo sapiens	IC50	nM	1.0
	15709844	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	COC(=O)c1cccc(NC(=O)C2(CN)CCN(c3ncnc4[nH]cc(C)c34)CC2)c1		CHEMBL3613598	<	IC50	nM	1.0	CHEMBL5932	Homo sapiens	IC50	nM	1.0
	15709845	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	Cc1c[nH]c2ncnc(N3CCC(CN)(C(=O)Nc4cccc(OC(=O)N(C)C)c4)CC3)c12		CHEMBL3356433	=	IC50	nM	1.6	CHEMBL5932	Homo sapiens	IC50	nM	1.6
	15709874	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	CCCOC(=O)c1cccc(NC(=O)C2(CN(C)C)CCN(c3ncnc4[nH]cc(C)c34)CC2)c1		CHEMBL3613606	=	IC50	nM	2.1	CHEMBL5932	Homo sapiens	IC50	nM	2.1
	15709875	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	Cc1c[nH]c2ncnc(N3CCC(CN(C)C)(C(=O)Nc4cccc(C(=O)OC(C)C)c4)CC3)c12		CHEMBL3613607	=	IC50	nM	2.2	CHEMBL5932	Homo sapiens	IC50	nM	2.2
	15709876	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	CCC(C)OC(=O)c1cccc(NC(=O)C2(CN(C)C)CCN(c3ncnc4[nH]cc(C)c34)CC2)c1		CHEMBL3613608	=	IC50	nM	4.6	CHEMBL5932	Homo sapiens	IC50	nM	4.6
	15709877	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	C#CCOC(=O)c1cccc(NC(=O)C2(CN(C)C)CCN(c3ncnc4[nH]cc(C)c34)CC2)c1		CHEMBL3613609	<	IC50	nM	1.0	CHEMBL5932	Homo sapiens	IC50	nM	1.0
	15709878	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	COC(=O)c1cccc(NC(=O)C2(CN(C)C)CCN(c3ncnc4[nH]ccc34)CC2)c1		CHEMBL3613610	=	IC50	nM	13.0	CHEMBL5932	Homo sapiens	IC50	nM	13.0
	15709879	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	COC(=O)c1cccc(NC(=O)C2(CN(C)C)CCN(c3ncnc4[nH]ncc34)CC2)c1		CHEMBL3613611	=	IC50	nM	193.0	CHEMBL5932	Homo sapiens	IC50	nM	193.0
	15709880	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	COC(=O)c1cccc(NC(=O)C2(CN(C)C)CCN(c3ccnc4[nH]ncc34)CC2)c1		CHEMBL3613612	=	IC50	nM	274.0	CHEMBL5932	Homo sapiens	IC50	nM	274.0
	15709881	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	COC(=O)c1cccc(NC(=O)C2(CN(C)C)CCN(c3ncnc4c3CC(=O)N4)CC2)c1		CHEMBL3613613	=	IC50	nM	1860.0	CHEMBL5932	Homo sapiens	IC50	nM	1860.0
	15709882	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	COC(=O)c1cccc(NC(=O)C2(N)CCN(c3ncnc4[nH]ccc34)CC2)c1		CHEMBL3613614	=	IC50	nM	9.6	CHEMBL5932	Homo sapiens	IC50	nM	9.6
	15709883	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	COC(=O)c1cccc(NC(=O)C2(N)CCN(c3ccncn3)CC2)c1		CHEMBL3613615	>	IC50	nM	10000.0	CHEMBL5932	Homo sapiens	IC50	nM	10000.0
	15709884	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	COC(=O)c1cccc(NC(=O)C2(N)CCN(c3cc(N)ncn3)CC2)c1		CHEMBL3613616	=	IC50	nM	4560.0	CHEMBL5932	Homo sapiens	IC50	nM	4560.0
	15709885	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	COC(=O)c1cccc(NC(=O)C2(N)CCN(c3ccnc(N)n3)CC2)c1		CHEMBL3613617	>	IC50	nM	10000.0	CHEMBL5932	Homo sapiens	IC50	nM	10000.0
	15709886	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	COC(=O)c1cccc(NC(=O)C2(N)CCN(c3cc(NC(C)=O)ncn3)CC2)c1		CHEMBL3613618	=	IC50	nM	494.0	CHEMBL5932	Homo sapiens	IC50	nM	494.0
	15709887	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	COC(=O)c1cccc(NC(=O)C2(N)CCN(c3ccnc(NC(C)=O)n3)CC2)c1		CHEMBL3613619	>	IC50	nM	10000.0	CHEMBL5932	Homo sapiens	IC50	nM	10000.0
	15709888	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	COC(=O)c1cccc(NC(=O)C2(CN(C)C)CCN(c3ncnc4[nH]cc(C#N)c34)CC2)c1		CHEMBL3613620	=	IC50	nM	4.0	CHEMBL5932	Homo sapiens	IC50	nM	4.0
	15709889	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	COC(=O)c1cccc(NC(=O)C2(CN(C)C)CCN(c3ncnc4[nH]cc(F)c34)CC2)c1		CHEMBL3613621	=	IC50	nM	2.8	CHEMBL5932	Homo sapiens	IC50	nM	2.8
	15709890	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	COC(=O)c1cccc(NC(=O)C2(CN(C)C)CCN(c3ncnc4[nH]c(C)cc34)CC2)c1		CHEMBL3613622	=	IC50	nM	8.0	CHEMBL5932	Homo sapiens	IC50	nM	8.0
	15709891	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	COC(=O)c1cccc(NC(=O)C2(CN(C)C)CCN(c3ncnc4[nH]c(C)c(C)c34)CC2)c1		CHEMBL3613623	=	IC50	nM	1.6	CHEMBL5932	Homo sapiens	IC50	nM	1.6
	15709892	CHEMBL3615477	Inhibition of LIMK2 (unknown origin) by radiometric assay	B	Cc1[nH]c2ncnc(N3CCC(CN(C)C)(C(=O)Nc4cccc(OC(=O)N(C)C)c4)CC3)c2c1C		CHEMBL3613624	=	IC50	nM	1.4	CHEMBL5932	Homo sapiens	IC50	nM	1.4
	15728372	CHEMBL3624102	Inhibition of human N-terminal GST-tagged LIMK2	B	Oc1ccc(Nc2ncc(-c3ccncc3-c3ccccc3Cl)s2)cc1		CHEMBL3623439	=	IC50	nM	1.0	CHEMBL5932	Homo sapiens	IC50	nM	1.0
	15728373	CHEMBL3624102	Inhibition of human N-terminal GST-tagged LIMK2	B	Cc1ccc(-c2cnccc2-c2cnc(NC(=O)C(C)C)s2)c(Cl)c1		CHEMBL3623442	=	IC50	nM	3.0	CHEMBL5932	Homo sapiens	IC50	nM	3.0
	15728374	CHEMBL3624102	Inhibition of human N-terminal GST-tagged LIMK2	B	COc1ccc(-c2cnccc2-c2cnc(NC(=O)C(C)C)s2)c(C(F)(F)F)c1		CHEMBL3623443	=	IC50	nM	48.0	CHEMBL5932	Homo sapiens	IC50	nM	48.0
	15728407	CHEMBL3624248	Inhibition of LIMK2 (unknown origin) at 10 uM	B	COc1ccc(-c2cnccc2-c2cnc(NC(=O)C(C)C)s2)c(C(F)(F)F)c1		CHEMBL3623443	>	Inhibition	%	90.0	CHEMBL5932	Homo sapiens	INH	%	90.0
	15756935	CHEMBL3631275	Inhibition of LIMK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	53.83	CHEMBL5932	Homo sapiens	INH	%	53.83
	15757788	CHEMBL3631275	Inhibition of LIMK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	99.12	CHEMBL5932	Homo sapiens	INH	%	99.12
	15758767	CHEMBL3631275	Inhibition of LIMK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC	Outside typical range	CHEMBL3628628	=	Inhibition	%	-15.7	CHEMBL5932	Homo sapiens	INH	%	-15.7
	16431883	CHEMBL3748237	Inhibition of human LIMK2 using cofilin as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL5932	Homo sapiens	IC50	uM	10.0
	16450892	CHEMBL3762908	Inhibition of LIMK2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	-2.1	CHEMBL5932	Homo sapiens	INH	%	-2.1
	16565713	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C1(C(=O)Nc2cccc(C(F)(F)F)c2)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1		CHEMBL3797769	=	IC50	nM	31.0	CHEMBL5932	Homo sapiens	IC50	nM	31.0
	16565714	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	Cc1cccc(NC(=O)C2(N(C)C)CCN(c3ncnc4[nH]c5c(c34)CCCC5)CC2)c1		CHEMBL3800515	=	IC50	nM	7.1	CHEMBL5932	Homo sapiens	IC50	nM	7.1
	16565715	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)c1ccc(NC(=O)C2(N(C)C)CCN(c3ncnc4[nH]c5c(c34)CCCC5)CC2)cc1		CHEMBL3798729	=	IC50	nM	22.0	CHEMBL5932	Homo sapiens	IC50	nM	22.0
	16565716	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	COc1ccc(NC(=O)C2(N(C)C)CCN(c3ncnc4[nH]c5c(c34)CCCC5)CC2)cc1		CHEMBL3799167	=	IC50	nM	41.0	CHEMBL5932	Homo sapiens	IC50	nM	41.0
	16565717	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CC(=O)Nc1ccc(NC(=O)C2(N(C)C)CCN(c3ncnc4[nH]c5c(c34)CCCC5)CC2)cc1		CHEMBL3799817	=	IC50	nM	122.0	CHEMBL5932	Homo sapiens	IC50	nM	122.0
	16565718	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C1(C(=O)Nc2ccc(OC(F)F)cc2)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1		CHEMBL3797422	=	IC50	nM	27.0	CHEMBL5932	Homo sapiens	IC50	nM	27.0
	16565719	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C1(C(=O)Nc2ccc(C#N)cc2)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1		CHEMBL3798698	=	IC50	nM	17.0	CHEMBL5932	Homo sapiens	IC50	nM	17.0
	16565720	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	Cc1ccccc1NC(=O)C1(N(C)C)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1		CHEMBL3799060	=	IC50	nM	700.0	CHEMBL5932	Homo sapiens	IC50	nM	700.0
	16565721	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C1(C(=O)Nc2ccccc2F)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1		CHEMBL3800529	=	IC50	nM	105.0	CHEMBL5932	Homo sapiens	IC50	nM	105.0
	16565722	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C1(C(=O)Nc2cccc(F)c2)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1		CHEMBL3798406	=	IC50	nM	3.7	CHEMBL5932	Homo sapiens	IC50	nM	3.7
	16565723	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C1(C(=O)Nc2ccc(F)cc2)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1		CHEMBL3799312	=	IC50	nM	12.0	CHEMBL5932	Homo sapiens	IC50	nM	12.0
	16565724	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C1(C(=O)Nc2ccccc2)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1		CHEMBL3800104	=	IC50	nM	4.5	CHEMBL5932	Homo sapiens	IC50	nM	4.5
	16565725	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C(=O)Oc1cccc(NC(=O)C2(N(C)C)CCN(c3ncnc4[nH]c5c(c34)CCCC5)CC2)c1		CHEMBL3798142	=	IC50	nM	0.2	CHEMBL5932	Homo sapiens	IC50	nM	0.2
	16565726	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)CC1(C(=O)Nc2cccc(OC(=O)N(C)C)c2)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1		CHEMBL3800259	=	IC50	nM	0.2	CHEMBL5932	Homo sapiens	IC50	nM	0.2
	16565727	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C(=O)Oc1cccc(NC(=O)C2(N)CCN(c3ncnc4[nH]c5c(c34)CCCC5)CC2)c1		CHEMBL3797469	=	IC50	nM	1.0	CHEMBL5932	Homo sapiens	IC50	nM	1.0
	16565728	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C(=O)Oc1cccc(NC(=O)C2(CN)CCN(c3ncnc4[nH]c5c(c34)CCCC5)CC2)c1		CHEMBL3797874	=	IC50	nM	0.7	CHEMBL5932	Homo sapiens	IC50	nM	0.7
	16565729	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	Cc1[nH]c2ncnc(N3CCC(CN)(C(=O)Nc4cccc(OC(=O)N(C)C)c4)CC3)c2c1C		CHEMBL3799326	=	IC50	nM	1.4	CHEMBL5932	Homo sapiens	IC50	nM	1.4
	16565730	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	Cc1c[nH]c2ncnc(N3CCC(CN)(C(=O)Nc4cccc(OC(=O)N(C)C)c4)CC3)c12		CHEMBL3356433	=	IC50	nM	1.6	CHEMBL5932	Homo sapiens	IC50	nM	1.6
	16565741	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C1(C(=O)Nc2cccc(C#N)c2)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1		CHEMBL3799054	=	IC50	nM	32.0	CHEMBL5932	Homo sapiens	IC50	nM	32.0
	16565742	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	COc1cccc(NC(=O)C2(N(C)C)CCN(c3ncnc4[nH]c5c(c34)CCCC5)CC2)c1		CHEMBL3800273	=	IC50	nM	2.0	CHEMBL5932	Homo sapiens	IC50	nM	2.0
	16565743	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CC(C)Oc1cccc(NC(=O)C2(N(C)C)CCN(c3ncnc4[nH]c5c(c34)CCCC5)CC2)c1		CHEMBL3798086	=	IC50	nM	4.8	CHEMBL5932	Homo sapiens	IC50	nM	4.8
	16565744	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C1(C(=O)Nc2cccc(CN3CCCCC3)c2)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1		CHEMBL3798226	=	IC50	nM	11.0	CHEMBL5932	Homo sapiens	IC50	nM	11.0
	16565745	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C1(C(=O)Nc2cccc(CN3CCOCC3)c2)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1		CHEMBL3800555	=	IC50	nM	62.0	CHEMBL5932	Homo sapiens	IC50	nM	62.0
	16565746	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	COC(=O)c1cccc(NC(=O)C2(N(C)C)CCN(c3ncnc4[nH]c5c(c34)CCCC5)CC2)c1		CHEMBL3797333	=	IC50	nM	13.0	CHEMBL5932	Homo sapiens	IC50	nM	13.0
	16565747	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	COC(=O)Cc1cccc(NC(=O)C2(N(C)C)CCN(c3ncnc4[nH]c5c(c34)CCCC5)CC2)c1		CHEMBL3800144	=	IC50	nM	0.8	CHEMBL5932	Homo sapiens	IC50	nM	0.8
	16565748	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CC(=O)Oc1cccc(NC(=O)C2(N(C)C)CCN(c3ncnc4[nH]c5c(c34)CCCC5)CC2)c1		CHEMBL3799236	=	IC50	nM	0.4	CHEMBL5932	Homo sapiens	IC50	nM	0.4
	16565749	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C1(C(=O)Nc2cccc(S(C)(=O)=O)c2)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1		CHEMBL3797875	=	IC50	nM	12.0	CHEMBL5932	Homo sapiens	IC50	nM	12.0
	16565750	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C1(C(=O)Nc2cccc(NS(C)(=O)=O)c2)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1		CHEMBL3800330	=	IC50	nM	0.4	CHEMBL5932	Homo sapiens	IC50	nM	0.4
	16565751	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C1(C(=O)Nc2cccc(-c3ccccc3)c2)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1		CHEMBL3797519	=	IC50	nM	0.7	CHEMBL5932	Homo sapiens	IC50	nM	0.7
	16565752	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C1(C(=O)Nc2cccc(-c3cccnc3)c2)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1		CHEMBL3800458	=	IC50	nM	0.1	CHEMBL5932	Homo sapiens	IC50	nM	0.1
	16565753	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C1(C(=O)Nc2cccc(-c3ccncc3)c2)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1		CHEMBL3798361	<	IC50	nM	0.1	CHEMBL5932	Homo sapiens	IC50	nM	0.1
	16565754	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C1(C(=O)Nc2cccc(-n3cccc3)c2)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1		CHEMBL3798662	=	IC50	nM	0.2	CHEMBL5932	Homo sapiens	IC50	nM	0.2
	16565755	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C1(C(=O)Nc2cccc(-c3ccco3)c2)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1		CHEMBL3799925	=	IC50	nM	0.3	CHEMBL5932	Homo sapiens	IC50	nM	0.3
	16565756	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C1(C(=O)Nc2cccc(-c3cccs3)c2)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1		CHEMBL3800357	=	IC50	nM	0.3	CHEMBL5932	Homo sapiens	IC50	nM	0.3
	16565757	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C1(C(=O)Nc2cccc(-n3ccnc3)c2)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1		CHEMBL3799358	<	IC50	nM	0.1	CHEMBL5932	Homo sapiens	IC50	nM	0.1
	16565758	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C1(C(=O)Nc2cccc(-c3cc[nH]n3)c2)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1		CHEMBL3798270	<	IC50	nM	0.1	CHEMBL5932	Homo sapiens	IC50	nM	0.1
	16565759	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C1(C(=O)Nc2cccc(-c3cnco3)c2)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1		CHEMBL3799695	=	IC50	nM	0.9	CHEMBL5932	Homo sapiens	IC50	nM	0.9
	16565760	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C1(C(=O)Nc2cccc(-n3cncn3)c2)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1		CHEMBL3798275	<	IC50	nM	0.1	CHEMBL5932	Homo sapiens	IC50	nM	0.1
	16565761	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C1(C(=O)Nc2cccc(-c3ncno3)c2)CCN(c2ncnc3[nH]c4c(c23)CCCC4)CC1		CHEMBL3799318	=	IC50	nM	0.1	CHEMBL5932	Homo sapiens	IC50	nM	0.1
	16565762	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C(=O)Oc1cccc(NC(=O)C2(N(C)C)CCN(c3ncnc4[nH]c5c(c34)CCC5)CC2)c1		CHEMBL3797634	=	IC50	nM	0.9	CHEMBL5932	Homo sapiens	IC50	nM	0.9
	16565763	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C(=O)Oc1cccc(NC(=O)C2(N(C)C)CCN(c3ncnc4[nH]c5c(c34)CC(F)(F)CC5)CC2)c1		CHEMBL3797658	=	IC50	nM	0.4	CHEMBL5932	Homo sapiens	IC50	nM	0.4
	16565764	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	COC(=O)c1cccc(NC(=O)C2(CN)CCN(c3ncnc4[nH]c5c(c34)CCCC5)CC2)c1		CHEMBL3797937	=	IC50	nM	23.0	CHEMBL5932	Homo sapiens	IC50	nM	23.0
	16565765	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	COC(=O)Cc1cccc(NC(=O)C2(CN)CCN(c3ncnc4[nH]c5c(c34)CCCC5)CC2)c1		CHEMBL3798651	<	IC50	nM	0.1	CHEMBL5932	Homo sapiens	IC50	nM	0.1
	16565766	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	COC(=O)Cc1cccc(NC(=O)C2(N(C)C)CCN(c3ncnc4[nH]c5c(c34)CCC5)CC2)c1		CHEMBL3800261	=	IC50	nM	1.4	CHEMBL5932	Homo sapiens	IC50	nM	1.4
	16565767	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	COC(=O)Cc1cccc(NC(=O)C2(CN)CCN(c3ncnc4[nH]c5c(c34)CCC5)CC2)c1		CHEMBL3799932	<	IC50	nM	0.1	CHEMBL5932	Homo sapiens	IC50	nM	0.1
	16565768	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	COC(=O)Cc1cccc(NC(=O)C2(N(C)C)CCN(c3ncnc4[nH]c5c(c34)CC(F)(F)CC5)CC2)c1		CHEMBL3799270	=	IC50	nM	0.2	CHEMBL5932	Homo sapiens	IC50	nM	0.2
	16565769	CHEMBL3801111	Inhibition of human LIMK2 using cofilin as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	COC(=O)Cc1cccc(NC(=O)C2(CN)CCN(c3ncnc4[nH]c5c(c34)CC(F)(F)CC5)CC2)c1		CHEMBL3798412	<	IC50	nM	0.1	CHEMBL5932	Homo sapiens	IC50	nM	0.1
Inactive	17909781	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909782	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Active	17909783	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	=	Kd	nM	52056.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	52056.0
Inactive	17909784	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909785	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909786	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909787	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909788	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909789	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909790	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909791	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909792	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909793	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909794	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909795	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909796	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909797	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909798	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909799	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909800	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909801	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909802	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909803	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909804	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909805	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909806	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909807	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909808	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909809	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909810	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909811	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909812	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909813	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909814	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909815	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909816	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909817	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909818	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909819	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909820	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909821	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909822	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909823	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909824	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909825	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909826	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909827	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909828	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909829	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909830	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909831	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909832	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909833	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909834	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909835	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Active	17909836	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	2547.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	2547.0
Inactive	17909837	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909838	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909839	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909840	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909841	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909842	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909843	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909844	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909845	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909846	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909847	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909848	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909849	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909850	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909851	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909852	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909853	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909854	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909855	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909856	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909857	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909858	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909859	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909860	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909861	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909862	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909863	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909864	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909865	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909866	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909867	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909868	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909869	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909870	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909871	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909872	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909873	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909874	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909875	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909876	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909877	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909878	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909879	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909880	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909881	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909882	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909883	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909884	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909885	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909886	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909887	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Active	17909888	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	=	Kd	nM	21770.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	21770.0
Inactive	17909889	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909890	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909891	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909892	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909893	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909894	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909895	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909896	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909897	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909898	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909899	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909900	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909901	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909902	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909903	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909904	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909905	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Active	17909906	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	965.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	965.0
Inactive	17909907	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Active	17909908	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	4340.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	4340.0
Inactive	17909909	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909910	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909911	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909912	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909913	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909914	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Active	17909915	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	=	Kd	nM	5306.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	5306.0
Inactive	17909916	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909917	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909918	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909919	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909920	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909921	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909922	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909923	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909924	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909925	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909926	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909927	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909928	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909929	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Active	17909930	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	15626.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	15626.0
Inactive	17909931	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909932	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909933	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909934	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909935	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909936	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909937	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Active	17909938	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	=	Kd	nM	3505.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	3505.0
Inactive	17909939	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909940	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909941	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909942	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909943	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909944	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Active	17909945	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	=	Kd	nM	477.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	477.0
Inactive	17909946	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909947	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909948	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909949	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909950	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909951	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909952	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909953	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909954	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909955	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Active	17909956	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	=	Kd	nM	96.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	96.0
Inactive	17909957	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909958	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909959	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909960	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909961	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909962	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909963	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909964	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909965	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909966	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909967	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909968	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909969	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909970	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909971	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909972	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909973	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909974	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909975	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909976	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909977	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909978	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909979	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909980	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909981	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909982	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909983	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909984	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909985	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909986	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909987	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909988	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909989	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Active	17909990	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	Kd	nM	82.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	82.0
Inactive	17909991	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Active	17909992	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	4432.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	4432.0
Active	17909993	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	=	Kd	nM	1840.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	1840.0
Inactive	17909994	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909995	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909996	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909997	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909998	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909999	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Active	17910000	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	205.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	205.0
Inactive	17910001	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910002	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910003	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910004	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910005	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910006	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910007	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910008	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910009	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910010	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910011	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910012	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910013	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910014	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910015	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Active	17910016	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	3758.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	3758.0
Inactive	17910017	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910018	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910019	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910020	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910021	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910022	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17910023	CHEMBL3991749	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL5932	Homo sapiens	Kd apparent	nM	30000.0
	18111187	CHEMBL4024001	Inhibition of human LIMK2 at 10 uM using cofilin as substrate in presence of [gamma33P]ATP relative to control	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Cl)C2=O)COc2cc(C#N)ccc21		CHEMBL4100398	>	Inhibition	%	50.0	CHEMBL5932	Homo sapiens	INH	%	50.0
	18114286	CHEMBL4025208	Inhibition of wild-type human full length LIMK2 (M1 to P638 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL5932	Homo sapiens	Activity	%	100.0
	18203732	CHEMBL4044019	Inhibition of wild-type human full length LIMK2 (M1 to P638 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL5932	Homo sapiens	Activity	%	100.0
	18253622	CHEMBL4055095	Inhibition of wild-type human full length LIMK2 (M1 to P638 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	92.0	CHEMBL5932	Homo sapiens	Activity	%	92.0
	18253623	CHEMBL4055095	Inhibition of wild-type human full length LIMK2 (M1 to P638 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL5932	Homo sapiens	Activity	%	100.0
	18440274	CHEMBL4157098	Binding affinity to wild-type human full length LIMK2 (M1 to P638 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	85.0	CHEMBL5932	Homo sapiens	Activity	%	85.0
	18484230	CHEMBL4185877	Binding affinity to wild-type human full length LIMK2 (M1 to P638 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL5932	Homo sapiens	Activity	%	100.0
	18484714	CHEMBL4185877	Binding affinity to wild-type human full length LIMK2 (M1 to P638 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	89.0	CHEMBL5932	Homo sapiens	Activity	%	89.0
	18655458	CHEMBL4230777	Binding affinity to wild-type human full length LIMK2 (M1 to P638 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL5932	Homo sapiens	Activity	%	100.0
	18752031	CHEMBL4264366	Binding affinity to wild-type human full length LIMK2 (M1 to P638 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	76.0	CHEMBL5932	Homo sapiens	Activity	%	76.0
	18858030	CHEMBL4307876	Binding affinity to wild-type human full length LIMK2 (M1 to P638 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	93.0	CHEMBL5932	Homo sapiens	Activity	%	93.0
	18892896	CHEMBL4314862	Inhibition of recombinant human LIMK2 assessed as residual activity at 10 uM by radiometric method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	105.5	CHEMBL5932	Homo sapiens	Activity	%	105.5
	18938037	CHEMBL4327745	Inhibition of human LIMK2 assessed as residual activity at 1 uM using cofilin as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	95.07	CHEMBL5932	Homo sapiens	Activity	%	95.07
	18938038	CHEMBL4327745	Inhibition of human LIMK2 assessed as residual activity at 1 uM using cofilin as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	94.16	CHEMBL5932	Homo sapiens	Activity	%	94.16
	18938590	CHEMBL4328109	Inhibition of human LIMK2 assessed as residual activity at 100 uM using cofilin as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL5932	Homo sapiens	Activity	%	65.0
	18938970	CHEMBL4328473	Inhibition of human LIMK2 using cofilin as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	102.0	CHEMBL5932	Homo sapiens	IC50	10'-7M	1.02
	18958941	CHEMBL4333463	Binding affinity to wild-type human full length LIMK2 (M1 to P638 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL5932	Homo sapiens	Activity	%	100.0
	18964403	CHEMBL4335140	Inhibition of recombinant human LIMK2 assessed as residual activity after 1 uM by radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	101.0	CHEMBL5932	Homo sapiens	Activity	%	101.0
	18964404	CHEMBL4335140	Inhibition of recombinant human LIMK2 assessed as residual activity after 1 uM by radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	95.0	CHEMBL5932	Homo sapiens	Activity	%	95.0
	18971955	CHEMBL4336965	Inhibition of recombinant human LIMK2 assessed as residual activity after 1 uM by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	56.0	CHEMBL5932	Homo sapiens	Activity	%	56.0
Not Active	19039726	CHEMBL4351916	Inhibition of recombinant human LIMK2 at 10 uM by radiometric method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL5932	Homo sapiens	INH		
	19052779	CHEMBL4355587	Binding affinity to human LIMK2	B	COc1n[nH]c2ncc(-c3cn(-c4c(F)ccc(NS(=O)(=O)c5cccc(-c6ccccc6)c5)c4F)nn3)cc12		CHEMBL4450810	=	Kd	nM	63.0	CHEMBL5932	Homo sapiens	Kd	nM	63.0
	19052793	CHEMBL4355551	Inhibition of human LIMK2 at 1 uM relative to control	B	COc1n[nH]c2ncc(-c3cn(-c4c(F)ccc(NS(=O)(=O)c5cccc(-c6ccccc6)c5)c4F)nn3)cc12		CHEMBL4450810	>	Inhibition	%	90.0	CHEMBL5932	Homo sapiens	INH	%	90.0
	19059654	CHEMBL4357955	Binding affinity to wild-type human full length LIMK2 (M1 to P638 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL5932	Homo sapiens	Activity	%	100.0
	19090219	CHEMBL4365793	Inhibition of wild-type human full length LIMK2 (M1 to P638 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL5932	Homo sapiens	Activity	%	100.0
	19091982	CHEMBL4366456	Inhibition of human LIMK2 at 100 nM using cofilin as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	2.98	CHEMBL5932	Homo sapiens	INH	%	2.98
	19114722	CHEMBL4371455	Binding affinity to LIMK2 in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Kd	nM	2784.0	CHEMBL5932	Homo sapiens	Kd(free)	uM	2.784
	19144940	CHEMBL4377956	Inhibition of recombinant human LIMK2 at 1 uM by radiometric method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	13.0	CHEMBL5932	Homo sapiens	INH	%	13.0
	19146991	CHEMBL4378801	Inhibition of human LIMK2 at 10 uM by radiometric assay relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	-8.0	CHEMBL5932	Homo sapiens	INH	%	-8.0
	19147682	CHEMBL4379077	Inhibition of human LIMK2 in presence of 10 uM of ATP by radiometric analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	=	IC50	nM	46.0	CHEMBL5932	Homo sapiens	IC50	uM	0.046
	19159482	CHEMBL4382586	Binding affinity to wild-type human full length LIMK2 (M1 to P638 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	73.0	CHEMBL5932	Homo sapiens	Activity	%	73.0
	19191525	CHEMBL4389305	Inhibition of wild-type human full length LIMK2 (M1 to P638 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL5932	Homo sapiens	INH	%	100.0
	19191968	CHEMBL4389782	Inhibition of wild-type human full length LIMK2 (M1 to P638 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL5932	Homo sapiens	INH	%	100.0
	19200224	CHEMBL4391408	Binding affinity to wild-type human full length LIMK2 (M1 to P638 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	60.0	CHEMBL5932	Homo sapiens	Activity	%	60.0
	19266479	CHEMBL4405429	Inhibition of wild-type human full length LIMK2 (M1 to P638 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL5932	Homo sapiens	INH	%	50.0
	19276023	CHEMBL4408026	Inhibition of recombinant human LIMK2 at 1 uM incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	42.0	CHEMBL5932	Homo sapiens	INH	%	42.0
	19411465	CHEMBL4427700	Inhibition of LIMK2 (unknown origin)	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	>=	IC50	nM	5000.0	CHEMBL5932	Homo sapiens	IC50	uM	5.0
	19411521	CHEMBL4427644	Inhibition of LIMK2 (unknown origin) at 1 uM relative to control	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	<=	Inhibition	%	16.0	CHEMBL5932	Homo sapiens	INH	%	16.0
Active	20657210	CHEMBL4617462	Inhibition of human LIMK2 at 1 uM by radiometric assay	B	COc1cccc(Cn2cnc3sc(-c4ccnc5[nH]ccc45)cc3c2=O)c1		CHEMBL4638815		Inhibition	%		CHEMBL5932	Homo sapiens	INH		
	22423507	CHEMBL4674329	Inhibition of human LIMK2 using cofilin as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	87.72	CHEMBL5932	Homo sapiens	Activity	%	87.72
	22423508	CHEMBL4674329	Inhibition of human LIMK2 using cofilin as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	97.09	CHEMBL5932	Homo sapiens	Activity	%	97.09
	22843695	CHEMBL4720681	Inhibition of human LIMK2 using cofilin as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	89.2	CHEMBL5932	Homo sapiens	IC50	10^-8M	8.92
	22844043	CHEMBL4721029	Inhibition of human LIMK2 assessed as residual activity using cofilin as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	98.77	CHEMBL5932	Homo sapiens	Activity	%	98.77
	22844919	CHEMBL4721594	Inhibition of wild-type human full length LIMK2 (M1 to P638 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	105.73	CHEMBL5932	Homo sapiens	Activity	%	105.73
	23122640	CHEMBL4804991	Inhibition of human LIMK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	93.0	CHEMBL5932	Homo sapiens	Activity	%	93.0
	23123335	CHEMBL4805579	Inhibition of human LIMK2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	96.0	CHEMBL5932	Homo sapiens	Activity	%	96.0
	23123794	CHEMBL4806038	Inhibition of DNA-tagged human LIMK2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL5932	Homo sapiens	Activity	%	100.0
	23124760	CHEMBL4806596	Inhibition of human LIMK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	91.0	CHEMBL5932	Homo sapiens	Activity	%	91.0
	23124761	CHEMBL4806596	Inhibition of human LIMK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	98.0	CHEMBL5932	Homo sapiens	Activity	%	98.0
	23128227	CHEMBL4807884	Inhibition of LIMK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL5932	Homo sapiens	Activity	%	75.0
	23128228	CHEMBL4807884	Inhibition of LIMK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL5932	Homo sapiens	Activity	%	75.0
	23128229	CHEMBL4807884	Inhibition of LIMK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL5932	Homo sapiens	Activity	%	75.0
Active	23277357	CHEMBL4836446	Inhibition of LIMK2 (unknown origin) at 10 uM	B	COc1cccc(CN2CCOc3cc(-c4ccncc4)ccc3C2=O)c1		CHEMBL4877688		Inhibition	%		CHEMBL5932	Homo sapiens	INH		
Not Active	23317475	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	80.0	CHEMBL5932	Homo sapiens	% Control	%	80.0
Not Active	23317943	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	90.0	CHEMBL5932	Homo sapiens	% Control	%	90.0
Not Active	23318610	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	72.0	CHEMBL5932	Homo sapiens	% Control	%	72.0
Not Active	23319093	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	82.0	CHEMBL5932	Homo sapiens	% Control	%	82.0
Not Active	23319730	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23320205	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	86.8	CHEMBL5932	Homo sapiens	% Control	%	86.8
Not Active	23320883	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23321351	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23321981	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23322449	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	64.0	CHEMBL5932	Homo sapiens	% Control	%	64.0
Not Active	23323138	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23323606	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23324460	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	91.1	CHEMBL5932	Homo sapiens	% Control	%	91.1
Not Active	23325095	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	90.0	CHEMBL5932	Homo sapiens	% Control	%	90.0
Not Active	23325563	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23326210	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	88.0	CHEMBL5932	Homo sapiens	% Control	%	88.0
Not Active	23326678	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	82.0	CHEMBL5932	Homo sapiens	% Control	%	82.0
Not Active	23327378	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23327846	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	94.0	CHEMBL5932	Homo sapiens	% Control	%	94.0
Not Active	23328433	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	95.0	CHEMBL5932	Homo sapiens	% Control	%	95.0
Not Active	23328901	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	84.0	CHEMBL5932	Homo sapiens	% Control	%	84.0
Not Active	23329395	CHEMBL4881102	LIMK2(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	104.0	CHEMBL5932	Homo sapiens	% residual kinase activity	%	104.0
Not Active	23329847	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23330315	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	95.0	CHEMBL5932	Homo sapiens	% Control	%	95.0
Not Active	23331071	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	95.0	CHEMBL5932	Homo sapiens	% Control	%	95.0
Not Active	23331539	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23332126	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	89.0	CHEMBL5932	Homo sapiens	% Control	%	89.0
Not Active	23332592	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	95.3	CHEMBL5932	Homo sapiens	% Control	%	95.3
Not Active	23333310	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	91.7	CHEMBL5932	Homo sapiens	% Control	%	91.7
Not Active	23333949	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	96.0	CHEMBL5932	Homo sapiens	% Control	%	96.0
Not Active	23334417	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23335396	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	79.0	CHEMBL5932	Homo sapiens	% Control	%	79.0
Not Active	23335864	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23336491	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	83.0	CHEMBL5932	Homo sapiens	% Control	%	83.0
Not Active	23336959	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	92.0	CHEMBL5932	Homo sapiens	% Control	%	92.0
Not Active	23337638	CHEMBL4882009	LIMK2 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	89.0	CHEMBL5932	Homo sapiens	% Ctrl	%	89.0
Not Active	23338040	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	85.0	CHEMBL5932	Homo sapiens	% Control	%	85.0
Not Active	23338508	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	85.0	CHEMBL5932	Homo sapiens	% Control	%	85.0
Not Active	23339120	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23339588	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23340225	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23340693	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23341350	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	91.0	CHEMBL5932	Homo sapiens	% Control	%	91.0
Not Active	23341818	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	98.0	CHEMBL5932	Homo sapiens	% Control	%	98.0
Not Active	23342434	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23342902	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23343532	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	96.0	CHEMBL5932	Homo sapiens	% Control	%	96.0
Not Active	23344000	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23344638	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23345211	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23345679	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	93.0	CHEMBL5932	Homo sapiens	% Control	%	93.0
Not Active	23346256	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	87.2	CHEMBL5932	Homo sapiens	% Control	%	87.2
Not Active	23346724	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23347326	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23347816	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	96.0	CHEMBL5932	Homo sapiens	% Control	%	96.0
Not Active	23348395	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23348863	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	91.0	CHEMBL5932	Homo sapiens	% Control	%	91.0
Not Active	23349450	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	87.0	CHEMBL5932	Homo sapiens	% Control	%	87.0
Not Active	23350068	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23350536	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23351141	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23351609	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23352088	CHEMBL4882779	LIMK2 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	0.6417	CHEMBL5932	Homo sapiens	% Inhibition	%	0.6417
Not Active	23352633	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	91.0	CHEMBL5932	Homo sapiens	% Control	%	91.0
Not Active	23353101	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	92.0	CHEMBL5932	Homo sapiens	% Control	%	92.0
Not Active	23353983	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23354451	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23355183	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23355651	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23356287	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23356755	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23357364	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23358011	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	88.0	CHEMBL5932	Homo sapiens	% Control	%	88.0
Not Active	23358479	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	95.0	CHEMBL5932	Homo sapiens	% Control	%	95.0
Not Active	23359065	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	96.2	CHEMBL5932	Homo sapiens	% Control	%	96.2
Not Active	23359663	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23360131	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23360716	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23361184	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23361757	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23362293	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	95.0	CHEMBL5932	Homo sapiens	% Control	%	95.0
Not Active	23362761	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	98.0	CHEMBL5932	Homo sapiens	% Control	%	98.0
Not Active	23364403	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	80.0	CHEMBL5932	Homo sapiens	% Control	%	80.0
Not Active	23364871	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	97.0	CHEMBL5932	Homo sapiens	% Control	%	97.0
Not Active	23365610	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	96.0	CHEMBL5932	Homo sapiens	% Control	%	96.0
Not Active	23366153	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	88.0	CHEMBL5932	Homo sapiens	% Control	%	88.0
Not Active	23366743	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23367211	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23367616	CHEMBL4883969	LIMK2 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	100.0	CHEMBL5932	Homo sapiens	% Residual activity with Skepinone-L	%	100.0
Not Active	23368089	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	97.0	CHEMBL5932	Homo sapiens	% Control	%	97.0
Not Active	23368557	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	93.0	CHEMBL5932	Homo sapiens	% Control	%	93.0
Not Active	23369156	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	88.0	CHEMBL5932	Homo sapiens	% Control	%	88.0
Not Active	23369624	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23370592	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	99.0	CHEMBL5932	Homo sapiens	% Control	%	99.0
Not Active	23371060	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	99.0	CHEMBL5932	Homo sapiens	% Control	%	99.0
Not Active	23371869	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	92.0	CHEMBL5932	Homo sapiens	% Control	%	92.0
Not Active	23372337	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
	23372778	CHEMBL4884743	LIMK2(LIM2LGV1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL5932	Homo sapiens	pIC50		6.0
	23373187	CHEMBL4885034	LIMK2(LIM2LGV1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL5932	Homo sapiens	pIC50		6.0
	23373547	CHEMBL4885324	LIMK2(LIM2LGV1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL5932	Homo sapiens	pIC50		6.0
Not Active	23375764	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23376232	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23376809	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23377277	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	92.0	CHEMBL5932	Homo sapiens	% Control	%	92.0
Not Active	23378137	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	88.0	CHEMBL5932	Homo sapiens	% Control	%	88.0
Not Active	23378605	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	90.0	CHEMBL5932	Homo sapiens	% Control	%	90.0
Not Active	23379772	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23380240	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	82.0	CHEMBL5932	Homo sapiens	% Control	%	82.0
Not Active	23380934	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	90.0	CHEMBL5932	Homo sapiens	% Control	%	90.0
Not Active	23381582	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23382050	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL5932	Homo sapiens	% Control	%	100.0
Not Active	23382674	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	87.0	CHEMBL5932	Homo sapiens	% Control	%	87.0
Not Active	23383142	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	94.0	CHEMBL5932	Homo sapiens	% Control	%	94.0
Not Active	23383841	CHEMBL4887466	LIMK2 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	95.0	CHEMBL5932	Homo sapiens	% Ctrl	%	95.0
Not Active	23384327	CHEMBL4887922	LIMK2(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	3.03	CHEMBL5932	Homo sapiens	% inhibition	%	3.03
Not Active	23385057	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	91.0	CHEMBL5932	Homo sapiens	% Control	%	91.0
Not Active	23385524	CHEMBL4879781	KinomeScan assay: inhibition of LIMK2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	87.0	CHEMBL5932	Homo sapiens	% Control	%	87.0
